11 November 2021
End of life care for people with diabetes continues to be under investigated and there is a dearth of guidelines, recommendations, and research into this topic. Caring for people with diabetes as they approach the last year, month and days of life often falls to non-diabetes specialist healthcare professionals, so it is important that clear clinical recommendations are accessible to promote good quality care.
Throughout a person with diabetes’ lifespan there is a real focus on meeting clinical targets and avoiding long term micro and macrovascular complications. It is understandable that in the last year of life the relaxation of targets can cause some concern and distress to both the person living with diabetes, their family or carers. The multiplicity of insulin and non-insulin therapies available can make end of life care complicated so it is important that information relating to these medications and possible withdrawal of diabetes therapies, in some cases, is easy to access.
The recommendations are updated regularly and this is the fourth edition.